Featured Editorial

31. Making AI Work For Clinical Trial Supply 3/20/2026

    AI is accelerating clinical trials, but supply teams risk falling behind. Explore how smarter planning, data, and experimentation turn AI into real operational impact.

32. Edge AI Is Reshaping How Clinical Trials Run 3/12/2026

    Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.

33. FDA's Elsa AI Switches From Claude To Gemini: What Sponsors Need To Know 3/12/2026

    Forced to cease using Anthropic's Claude for its Elsa generative AI assistant, the FDA is switching to Gemini. Legal experts Kimberly Chew, Esq., and Michael Yang, Esq., explain the implications for trade secrets and data security risks.

34. How Deep Learning Is Changing Clinical Trial Design, Execution, And Analysis In 2026 3/10/2026

    Deep learning is reshaping clinical trial design, execution, and analysis. Learn how to deploy it safely, measurably, and at scale with help from life sciences consultant and MIT industry advisor Partha Anbil.

35. Telehealth In Clinical Trials: What Sites And Patients Think 3/4/2026

    Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.

36. Pick The Right PV Technology With Help From A Safety Data Management Expert 2/27/2026

    Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.

37. Telehealth In Clinical Trials: What You Need To Know 2/26/2026

    Telehealth is a tool, not a trial design. Learn how televisits, ePRO, and remote monitoring fit into traditional, hybrid, and decentralized clinical trials.

38. Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1) 2/25/2026

    Understand why cloud infrastructure is foundational to hybrid and decentralized trials and what critical trial activities it enables with reduced operational friction.

39. Safe And Sustainable DCTs and Hybrid Trials (Part 2) 2/25/2026

    In part two of this series, learn practical cloud architectural patterns, governance structures, and operating mechanisms that allow sponsors to run hybrid and decentralized trials.

40. Forget More Clinical Tech, We Need More Adoption 2/23/2026

    At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. From evolving FDA inspection expectations to the normalization (and lingering misconceptions) of decentralized trials, Lipset argues progress will depend less on new technology and more on scaling what already works.